Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.
Journal: Cancer immunology research
Published: March 05, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9+ monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026
A Tacrolimus Population Pharmacokinetic Model for Adult Allogeneic Hematopoietic Cell Transplant Recipients Provides Clinical Opportunities for Precision Dosing.
Journal: Clinical pharmacokinetics
Published: May 14, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults.
Journal: Open forum infectious diseases
Published: April 14, 2025
The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Journal: Open forum infectious diseases
Published: December 20, 2024
Corrigendum to "Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy" [Biomaterials 312 (2025) 122750.
Journal: Biomaterials
Published: September 15, 2024
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: August 04, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults.
Journal: medRxiv : the preprint server for health sciences
Published: July 23, 2024
Tumor-specific surface marker-independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry.
Journal: The Journal of clinical investigation
Published: July 19, 2024
A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD.
Journal: Blood advances
Published: May 16, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy.
Journal: Biomaterials
Published: April 09, 2024
Optimized Fabrication of Dendritic Mesoporous Silica Nanoparticles as Efficient Delivery System for Cancer Immunotherapy.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: April 08, 2024
Last Updated: 09/26/2026